This is a fantastic article on the latest in cutti
Post# of 30028
The article also has important relevance to MiMedx (amniotic allografts for heart tissue/orthopedics),AxoGen (peripheral nerve repair w/o donor sites) and Amarantus and MANF (gene therapy for Parkinson's and MANF's ability to improve retinal pigmentosa if Amarantus can ever get back on its feet again). But the real gem is Recell and Avita Medical, which expects to get FDA approval for partial thickness burn injuries this year.
http://www.healthline.com/health-news/regener...t-future#3
$AMBS $AVMXY $MDXG $AXGN